Promoter Nikita Hiren Patel has sold 3,26,104 shares of Bacil Pharma Ltd, reducing her stake from 19.44% to 17.17%. The transaction occurred in the open market on June 8-9, 2026.
Bacil Pharma: Promoter Reduces Stake
Nikita Hiren Patel, a promoter of Bacil Pharma Ltd, has sold 3,26,104 equity shares.
What just happened
The promoter's stake in Bacil Pharma has decreased from 19.44% to 17.17% after selling 3,26,104 shares on June 8 and 9, 2026.
Why this matters
This change in shareholding pattern indicates a reduction in the promoter's direct investment in the company, which investors typically monitor closely.
The backstory
Nikita Hiren Patel previously held 27,90,000 shares, representing 19.44% of the company's 1,43,53,000 equity shares. The sale reduces this to 24,63,896 shares.
What changes now
The promoter's holding is now 17.17%. This is a routine disclosure under SEBI regulations.
Risks to watch
While this is a personal divestment, significant reductions by promoters can sometimes signal reduced confidence, though no operational information suggests this here.
Peer comparison
Shareholding changes are common across the pharmaceutical sector as investors rebalance portfolios.
Context metrics (time-bound)
- Transaction Dates: 08-06-2026 and 09-06-2026
- Shares Sold: 3,26,104
- Pre-sale Holding: 19.44%
- Post-sale Holding: 17.17%
